Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. E75 Her2 Peptide
2. Her2 (369-377)
3. Her2 Peptide (369-377)
4. Nelipepimut-5
1. Kifgslafl
2. 160212-35-1
3. Neuvax
4. Neuvax Vaccine
5. L-lysyl-l-isoleucyl-l-phenylalanylglycyl-l-seryl-l-leucyl-l-alanyl-l-phenylalanyl-l-leucine
6. Nelipepimut-s [usan]
7. Unii-7m0a29cd8b
8. E75 Peptide
9. 7m0a29cd8b
10. Chembl386200
11. Dtxsid80166835
12. Bdbm50409332
13. E-75
14. Her-2(369-377)
15. Hy-106204
16. Cs-0025241
17. Q27268544
18. (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic Acid
19. Human Receptor Tyrosine-protein Kinase Erbb-2 (proto-oncogene Neu, Tyrosine Kinase- Type Cell Surface Receptor Her2, Cd340)-(347-355)-peptide
| Molecular Weight | 995.2 g/mol |
|---|---|
| Molecular Formula | C50H78N10O11 |
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 32 |
| Exact Mass | 994.58515334 g/mol |
| Monoisotopic Mass | 994.58515334 g/mol |
| Topological Polar Surface Area | 342 Ų |
| Heavy Atom Count | 71 |
| Formal Charge | 0 |
| Complexity | 1720 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in prostate cancer and breast cancer.
NeuVax is a HER2/neu peptide-based T-cell immunotherapy aimed at preventing disease recurrence and prolonging survival in cancer patients that have tumors which express the HER2/neu oncoprotein. To date, clinical study results have demonstrated that NeuVax significantly reduces the rate of cancer recurrence while showing minimal side effects. [Apthera Press release]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
94
PharmaCompass offers a list of Nelipepimut-S API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nelipepimut-S manufacturer or Nelipepimut-S supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nelipepimut-S manufacturer or Nelipepimut-S supplier.
PharmaCompass also assists you with knowing the Nelipepimut-S API Price utilized in the formulation of products. Nelipepimut-S API Price is not always fixed or binding as the Nelipepimut-S Price is obtained through a variety of data sources. The Nelipepimut-S Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A E75 peptide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E75 peptide, including repackagers and relabelers. The FDA regulates E75 peptide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E75 peptide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A E75 peptide supplier is an individual or a company that provides E75 peptide active pharmaceutical ingredient (API) or E75 peptide finished formulations upon request. The E75 peptide suppliers may include E75 peptide API manufacturers, exporters, distributors and traders.
E75 peptide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of E75 peptide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right E75 peptide GMP manufacturer or E75 peptide GMP API supplier for your needs.
A E75 peptide CoA (Certificate of Analysis) is a formal document that attests to E75 peptide's compliance with E75 peptide specifications and serves as a tool for batch-level quality control.
E75 peptide CoA mostly includes findings from lab analyses of a specific batch. For each E75 peptide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
E75 peptide may be tested according to a variety of international standards, such as European Pharmacopoeia (E75 peptide EP), E75 peptide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (E75 peptide USP).
